Tasly Pharmaceutical Group Co., Ltd clinical trials

Acquired by China Resources Pharmaceutical Group Limited, Mar 27, 2025 · source ↗

The registry lists 32 studies whose lead sponsor is Tasly Pharmaceutical Group Co., Ltd. 17 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 23, 2026.

Studies

Recruiting first, then most recently updated. Showing 32 of 32. All China Resources Pharmaceutical Group Limited studies →

• Qishen Yiqi Dripping Pills in Treatment of Chronic Heart FailUreRecruitingNCT07687186Phase 3

  Sponsor listed in the registry: Tasly Pharmaceutical Group Co., Ltd · First submitted after Tasly Pharmaceutical Group Co., Ltd became part of China Resources Pharmaceutical Group Limited

• A Study of B2065 in Patients With Acute Ischemic StrokeRecruitingNCT07371624Phase 1/2

  Sponsor listed in the registry: Tasly Pharmaceutical Group Co., Ltd · First submitted after Tasly Pharmaceutical Group Co., Ltd became part of China Resources Pharmaceutical Group Limited

• A Study of the Effectiveness and Safety of JS1-1-01 Tablet in Patients With Moderate to Severe DepressionNot yet recruitingNCT07485595Phase 2/3

  Sponsor listed in the registry: Tasly Pharmaceutical Group Co., Ltd · First submitted after Tasly Pharmaceutical Group Co., Ltd became part of China Resources Pharmaceutical Group Limited

• A Clinical Trial Evaluating the Efficacy and Safety of Sanhuang Jingshiming Pills in the Treatment of nAMDNot yet recruitingNCT07269769Phase 3

  Sponsor listed in the registry: Tasly Pharmaceutical Group Co., Ltd · First submitted after Tasly Pharmaceutical Group Co., Ltd became part of China Resources Pharmaceutical Group Limited

• TSL2109 Capsules in Advanced Solid Tumor Patients: Safety, Tolerability, PK and Preliminary EfficacyRecruitingNCT07514065Phase 1

  Sponsor listed in the registry: Tasly Pharmaceutical Group Co., Ltd · First submitted after Tasly Pharmaceutical Group Co., Ltd became part of China Resources Pharmaceutical Group Limited

• A Clinical Trial of P134 Cells in Recurrent GlioblastomaRecruitingNCT07318818Phase 1/2

  Sponsor listed in the registry: Tasly Pharmaceutical Group Co., Ltd · First submitted after Tasly Pharmaceutical Group Co., Ltd became part of China Resources Pharmaceutical Group Limited

• A Study of Lianxiaxiaopi Granules in the Treatment of Postprandial Distress SyndromeRecruitingNCT06696261Phase 3

  Sponsor listed in the registry: Tasly Pharmaceutical Group Co., Ltd · First submitted before Tasly Pharmaceutical Group Co., Ltd became part of China Resources Pharmaceutical Group Limited

• A Phase I/II Clinical Trial of Intramyocardial Injection of HucMSCs for the Treatment of Chronic Heart FailureRecruitingNCT07265349Phase 1/2

  Sponsor listed in the registry: Tasly Pharmaceutical Group Co., Ltd · First submitted after Tasly Pharmaceutical Group Co., Ltd became part of China Resources Pharmaceutical Group Limited

• Phase III Trial of Susu Zhike Granules in Children With Cold-cough Syndrome for Acute Cough TreatmentNot yet recruitingNCT06773117Phase 3

  Sponsor listed in the registry: Tasly Pharmaceutical Group Co., Ltd · First submitted before Tasly Pharmaceutical Group Co., Ltd became part of China Resources Pharmaceutical Group Limited

• Efficacy and Safety of Changkang Granules in the Treatment of Irritable Bowel Syndrome With Predominant Diarrhea (Liver qi Affecting the Spleen Pattern)Not yet recruitingNCT06753890Phase 3

  Sponsor listed in the registry: Tasly Pharmaceutical Group Co., Ltd · First submitted before Tasly Pharmaceutical Group Co., Ltd became part of China Resources Pharmaceutical Group Limited

• A Study of Comparing Overall Improvement of Patients With Spondyloarthritis Treated With Jitongning Tablets and PlaceboRecruitingNCT06000956Phase 3

  Sponsor listed in the registry: Tasly Pharmaceutical Group Co., Ltd · First submitted before Tasly Pharmaceutical Group Co., Ltd became part of China Resources Pharmaceutical Group Limited

• A Study of the Efficacy and Safety of Antiwei Granules in the Treatment of Common ColdRecruitingNCT06697886Phase 3

  Sponsor listed in the registry: Tasly Pharmaceutical Group Co., Ltd · First submitted before Tasly Pharmaceutical Group Co., Ltd became part of China Resources Pharmaceutical Group Limited

• Efficacy and Safety of Xiangjurupining Capsule for Hyperplasia of Mammary GlandsRecruitingNCT06685978Phase 3

  Sponsor listed in the registry: Tasly Pharmaceutical Group Co., Ltd · First submitted before Tasly Pharmaceutical Group Co., Ltd became part of China Resources Pharmaceutical Group Limited

• Efficacy and Safety of Jia Shen Tablets in Chronic Heart FailureNot yet recruitingNCT06669169Phase 2

  Sponsor listed in the registry: Tasly Pharmaceutical Group Co., Ltd · First submitted before Tasly Pharmaceutical Group Co., Ltd became part of China Resources Pharmaceutical Group Limited

• Efficacy and Safety of Jiuweihuaban Pill for Treating Plaque PsoriasisRecruitingNCT06058546Phase 2

  Sponsor listed in the registry: Tasly Pharmaceutical Group Co., Ltd · First submitted before Tasly Pharmaceutical Group Co., Ltd became part of China Resources Pharmaceutical Group Limited

• HuHuangLianzonggan Capsule in Subjects With Nonalcoholic Steatohepatitis: a Phase 2 tRial(HHL-HEPAR)RecruitingNCT05632861Phase 2

  Sponsor listed in the registry: Tasly Pharmaceutical Group Co., Ltd · First submitted before Tasly Pharmaceutical Group Co., Ltd became part of China Resources Pharmaceutical Group Limited

• Pharmacokinetic and Pharmacodynamic of Jia Shen Tablets in Chronic Heart FailureRecruitingNCT06348498Phase 1

  Sponsor listed in the registry: Tasly Pharmaceutical Group Co., Ltd · First submitted before Tasly Pharmaceutical Group Co., Ltd became part of China Resources Pharmaceutical Group Limited

• Efficacy and Safety of QiShen YiQi Dripping Pills in the Treatment of Diabetic Kidney Disease (Syndrome of Qi Deficiency With Blood Stasis)CompletedNCT06006689Phase 2

  Sponsor listed in the registry: Tasly Pharmaceutical Group Co., Ltd · First submitted before Tasly Pharmaceutical Group Co., Ltd became part of China Resources Pharmaceutical Group Limited

• Efficacy and Safety of QiShen YiQi Dripping Pills in Chronic Heart FailureCompletedNCT04983043Phase 2

  Sponsor listed in the registry: Tasly Pharmaceutical Group Co., Ltd · First submitted before Tasly Pharmaceutical Group Co., Ltd became part of China Resources Pharmaceutical Group Limited

• Efficacy and Safety of Qishenyiqi Dripping Pills for Treating Chronic Heart Failure With Preserved Ejection FractionCompletedNCT04944706Phase 2

  Sponsor listed in the registry: Tasly Pharmaceutical Group Co., Ltd · First submitted before Tasly Pharmaceutical Group Co., Ltd became part of China Resources Pharmaceutical Group Limited

• A Study of the Safety and Efficacy of Pimavanserin in Patients With Parkinson's Disease PsychosisCompletedNCT06068465Phase 3

  Sponsor listed in the registry: Tasly Pharmaceutical Group Co., Ltd · First submitted before Tasly Pharmaceutical Group Co., Ltd became part of China Resources Pharmaceutical Group Limited

• A Study of STRO-002 in Chinese Adults With Epithelial Ovarian Cancer and Other Advanced Malignant Solid TumorsCompletedNCT06238687Phase 1/2

  Sponsor listed in the registry: Tasly Pharmaceutical Group Co., Ltd · First submitted before Tasly Pharmaceutical Group Co., Ltd became part of China Resources Pharmaceutical Group Limited

• A Study to Evaluate Efficacy and Safety of Qingzhu Granules in the Treatment of Acute Gouty ArthritisCompletedNCT06068478Phase 3

  Sponsor listed in the registry: Tasly Pharmaceutical Group Co., Ltd · First submitted before Tasly Pharmaceutical Group Co., Ltd became part of China Resources Pharmaceutical Group Limited

• A Study of the Effectiveness and Safety of JS1-1-01 in Patients With Moderate to Severe DepressionCompletedNCT06259526Phase 2

  Sponsor listed in the registry: Tasly Pharmaceutical Group Co., Ltd · First submitted before Tasly Pharmaceutical Group Co., Ltd became part of China Resources Pharmaceutical Group Limited

• A Study of the Safety,Tolerability,and Pharmacokinetics of Multiple-Ascending Dose JS1-1-01 in Healty Subjects.CompletedNCT05656274Phase 1

  Sponsor listed in the registry: Tasly Pharmaceutical Group Co., Ltd · First submitted before Tasly Pharmaceutical Group Co., Ltd became part of China Resources Pharmaceutical Group Limited

• A Study of Xiangjurupining Capsule in the Treatment of Hyperplasia of Breast (Liver Stagnation and Phlegm Coagulation)CompletedNCT04229706Phase 2

  Sponsor listed in the registry: Tasly Pharmaceutical Group Co., Ltd · First submitted before Tasly Pharmaceutical Group Co., Ltd became part of China Resources Pharmaceutical Group Limited

• Efficacy and Safety of Changkang Granule in the Treatment of Diarrhea-predominant Irritable Bowel Syndrome (IBS-D)CompletedNCT04492787Phase 2

  Sponsor listed in the registry: Tasly Pharmaceutical Group Co., Ltd · First submitted before Tasly Pharmaceutical Group Co., Ltd became part of China Resources Pharmaceutical Group Limited

• Efficacy and Safety of Susu Zhike Granules for Treating Acute Cough Due to Common Cold With Cold-cough Syndrome in ChildrenCompletedNCT04457011Phase 2

  Sponsor listed in the registry: Tasly Pharmaceutical Group Co., Ltd · First submitted before Tasly Pharmaceutical Group Co., Ltd became part of China Resources Pharmaceutical Group Limited

• A Phase Ⅱ Clinical Study of Sanhuangjingshimingwan in Wet( Neovascular)Age-related Macular Degeneration(wAMD) SubjectsCompletedNCT04486963Phase 2

  Sponsor listed in the registry: Tasly Pharmaceutical Group Co., Ltd · First submitted before Tasly Pharmaceutical Group Co., Ltd became part of China Resources Pharmaceutical Group Limited

• A Study to Evaluate the Tolerability and Pharmacokinetics of Jiashen Tablets in Healthy SubjectsCompletedNCT04164290Phase 1

  Sponsor listed in the registry: Tasly Pharmaceutical Group Co., Ltd · First submitted before Tasly Pharmaceutical Group Co., Ltd became part of China Resources Pharmaceutical Group Limited

• Study of Jitongning Tablet to Treat SpondyloarthritisCompletedNCT03932019Phase 2

  Sponsor listed in the registry: Tasly Pharmaceutical Group Co., Ltd · First submitted before Tasly Pharmaceutical Group Co., Ltd became part of China Resources Pharmaceutical Group Limited

• A Study of Qishenyiqi Dripping Pills in Healthy ParticipantsCompletedNCT04471298Phase 1

  Sponsor listed in the registry: Tasly Pharmaceutical Group Co., Ltd · First submitted before Tasly Pharmaceutical Group Co., Ltd became part of China Resources Pharmaceutical Group Limited